|
Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
| 1.895 USD | +0.79% |
|
-4.10% | +31.60% |
| Apr. 23 | Silo Pharma, Inc. Announces Positive Results for Intranasal PTSD Treatment | CI |
| Apr. 10 | Silo Pharma Says It Exercised Option to License Alzheimer's Therapeutic From Columbia University | MT |
Silo Pharma, Inc. (NasdaqCM:SILO) announces a share repurchase program. Under the program, the company will repurchase up to $1 million worth of its common stock. As of November 10, 2022, the company had 3,138,797 million shares of common stock outstanding.
The repurchase program is valid until December 31, 2023.
| 1st Jan change | Capi. | |
|---|---|---|
| +31.60% | 5.35M | |
| -4.66% | 87.53B | |
| +2.63% | 40.42B | |
| -19.97% | 29.48B | |
| +57.86% | 25.43B | |
| -17.58% | 11.49B | |
| -44.02% | 11.3B | |
| -15.61% | 11.1B | |
| +4.94% | 8.75B | |
| -8.42% | 7.99B |
SILO PHARMA, INC. 
